HLL Lifecare

From Wikipedia, the free encyclopedia
Jump to: navigation, search
HLL Lifecare Limited
Type Public
Industry Health Care
Founded 1966, Thiruvananthapuram
Headquarters Thiruvananthapuram, Kerala, India
Key people Dr. M. Ayyappan,
Chairman & Managing Director
Products Condoms
Hormonal contraception
Surgical Equipment
Revenue IncreaseINR 244 crores
(FY 2005-2006)
Website www.lifecarehll.com

HLL Lifecare Limited (formerly Hindustan Latex Limited) (HLL) is an Indian healthcare products manufacturing company based in Thiruvananthapuram, Kerala, India. A Government of India -owned corporation (Public-sector undertaking), it produces health care products, including condoms,Surgical Sutures, Hydrocephalus Shunts, Tissue Expanders, blood bags, and contraceptive pills. One of HLL's contraceptive products is ormeloxifene, branded as Saheli, a non-hormonal non-steroid weekly oral contraceptive.[1] In 2012, HLL announced a polymerase chain reaction based duplex test kit for chikungunya and dengue fever tests in collaboration with the Rajiv Gandhi Centre for Biotechnology, Trivandrum.[2]

History[edit]

Earlier Hindustan Lever Limited, had the same acronym HLL. But Hindustan Lever Limited changed their name as Hindustan Unilever Limited with acronym as HUL. Today HLL means HLL Lifecare Limited.

In 2005, it established LifeSpring Hospitals, a 50-50 joint venture with the Acumen Fund, a U.S.-based nonprofit global venture philanthropy fund, to provide low-cost maternity services, starting at Hyderabad, today it has nine hospitals across Andhra Pradesh state today.[3][4][5][6]

In February 2014, HLL acquired 74% Equity in Goa Antibiotics and Pharmaceuticals Ltd.[7]

See also[edit]

References[edit]

  1. ^ Hindustan Latex is world's largest condom producer Financial Express, Nov 24, 2007.
  2. ^ "HLL Lifecare to launch chikungunya, dengue diagonstic kits". The Times Of India. 2012-08-08. 
  3. ^ "LifeSpring Hospitals". Acumen Fund website. 
  4. ^ "Current Investors". LifeSpring website. 
  5. ^ "How services firms in India are using disruptive innovation". Mint (newspaper). Feb 3, 2011. 
  6. ^ "HLL Case Study". siteresources.worldbank. 
  7. ^ "HLL Lifecare acquires 74% Stake in Goa Antibiotics Ltd". IANS. news.biharprabha.com. Retrieved 25 February 2014. 

External links[edit]